LIFE:ATAI
atai Life Sciences
- Stock
Last Close
1.52
22/11 21:00
Market Cap
199.68M
Beta: -
Volume Today
2.09M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
net income | -24.38M - | -178.63M 632.55% | -174.24M 2.45% | -157.42M 9.66% | -40.22M 74.45% | |
depreciation and amortization | 6K - | 24K 300% | 47K 95.83% | 168K 257.45% | 319.00K 89.88% | |
deferred income tax | 7.54M - | 56.35M 647.69% | 39.13M 30.55% | 5.07M 87.03% | -124K 102.44% | |
stock based compensation | 57K - | 67.16M 117,721.05% | 63.36M 5.65% | 42.38M 33.12% | 32.98M 22.17% | |
change in working capital | -126K - | 4.45M 3,631.75% | -7.60M 270.88% | -3.33M 56.14% | 7.47M 323.96% | |
accounts receivables | -2.01M - | |||||
inventory | 2.01M - | |||||
accounts payables | 249K - | 1.70M 584.34% | 2.30M 34.98% | -3.03M 231.91% | 2.14M 170.47% | |
other working capital | -375K - | 2.75M 832.27% | -9.90M 460.67% | -301K 96.96% | 5.33M 1,871.10% | |
other non cash items | 9.06M - | 29.88M 229.63% | 16.06M 46.26% | 8.67M 46.02% | -84.54M 1,075.31% | |
net cash provided by operating activities | -7.85M - | -20.77M 164.67% | -63.25M 204.57% | -104.47M 65.18% | -84.12M 19.48% | |
investments in property plant and equipment | -19K - | -59K 210.53% | -1.13M 1,811.86% | -1.02M 9.22% | -590.00K 42.38% | |
acquisitions net | -456K - | -2.09M 357.89% | -52.94M 2,435.30% | -1 - | ||
purchases of investments | -11.55M - | -23.92M 107.10% | -23.66M 1.10% | -309.66M 1,208.89% | -185.26M 40.17% | |
sales maturities of investments | 10.31M - | -955K - | 226.83M 23,852.25% | 139.47M 38.51% | ||
other investing activites | -7.32M - | -2.20M 69.89% | -2.60M 17.88% | -3M 15.47% | -6.91M 130.40% | |
net cash used for investing activites | -9.03M - | -28.27M 213.04% | -81.28M 187.49% | -86.85M 6.86% | -53.29M 38.63% | |
debt repayment | -32.50M - | -1.59M 95.11% | -13.26M 734.70% | -8.58M 35.27% | ||
common stock issued | 42.68M - | 82.44M 93.14% | 409.88M 397.20% | 4.64M 98.87% | 225.00K 95.15% | |
common stock repurchased | ||||||
dividends paid | ||||||
other financing activites | -2.29M - | 63.12M 2,850.15% | 1.57M 97.52% | 29.40M 1,777.65% | 2 100.00% | |
net cash used provided by financing activities | 40.39M - | 113.05M 179.91% | 409.86M 262.54% | 20.79M 94.93% | -8.35M 140.20% | |
effect of forex changes on cash | -372K - | 3.17M 951.88% | -320K 110.10% | -1.12M 250.94% | 189K 116.83% | |
net change in cash | 23.14M - | 67.18M 190.34% | 265.02M 294.47% | -171.65M 164.77% | -145.58M 15.19% | |
cash at beginning of period | 6.92M - | 30.06M 334.30% | 97.25M 223.48% | 362.27M 272.53% | 190.61M 47.38% | |
cash at end of period | 30.06M - | 97.25M 223.48% | 362.27M 272.53% | 190.61M 47.38% | 45.03M 76.37% | |
operating cash flow | -7.85M - | -20.77M 164.67% | -63.25M 204.57% | -104.47M 65.18% | -84.12M 19.48% | |
capital expenditure | -19K - | -59K 210.53% | -1.13M 1,811.86% | -1.02M 9.22% | -590.00K 42.38% | |
free cash flow | -7.87M - | -20.82M 164.78% | -64.37M 209.12% | -105.49M 63.87% | -84.71M 19.70% |
All numbers in USD (except ratios and percentages)